| Literature DB >> 31424427 |
Masaki Uchida1, Bernhard Maier2, Hitesh Kumar Waghwani1, Ekaterina Selivanovitch1, S Louise Pay2, John Avera1, EJun Yun1, Ruben M Sandoval2, Bruce A Molitoris2, Amy Zollman2, Trevor Douglas1, Takashi Hato2.
Abstract
Nature exploits cage-like proteins for a variety of biological purposes, from molecular packaging and cargo delivery to catalysis. These cage-like proteins are of immense importance in nanomedicine due to their propensity to self-assemble from simple identical building blocks to highly ordered architecture and the design flexibility afforded by protein engineering. However, delivery of protein nanocages to the renal tubules remains a major challenge because of the glomerular filtration barrier, which effectively excludes conventional size nanocages. Here, we show that DNA-binding protein from starved cells (Dps) - the extremely small archaeal antioxidant nanocage - is able to cross the glomerular filtration barrier and is endocytosed by the renal proximal tubules. Using a model of endotoxemia, we present an example of the way in which proximal tubule-selective Dps nanocages can limit the degree of endotoxin-induced kidney injury. This was accomplished by amplifying the endogenous antioxidant property of Dps with addition of a dinuclear manganese cluster. Dps is the first-in-class protein cage nanoparticle that can be targeted to renal proximal tubules through glomerular filtration. In addition to its therapeutic potential, chemical and genetic engineering of Dps will offer a nanoplatform to advance our understanding of the physiology and pathophysiology of glomerular filtration and tubular endocytosis.Entities:
Keywords: Diagnostic imaging; Drug therapy; Nanotechnology; Nephrology
Mesh:
Substances:
Year: 2019 PMID: 31424427 PMCID: PMC6715384 DOI: 10.1172/JCI127511
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808